Last update:
Clinical pharmacology news
Should pregnant women worry about taking Tylenol? 20-year sibling-matched study finds no link to autism or ADHD
Tylenol (also known as acetaminophen or paracetamol) is one of the most widely used over-the-counter options for easing pain and reducing fever, including during pregnancy. More recently, safety concerns around use during ...
23 hours ago
1
10
Rare muscle disorder mutations reveal a precision medicine strategy
Scientists at the University of California San Diego have uncovered how genetic mutations cause a rare group of inherited neuromuscular disorders and identified promising new strategies to correct them, including a potential ...
21 hours ago
0
5
Discovery could help prevent cancer drug resistance before it starts
Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of California, Davis, shows how cancers adapt to evade a class of anti-tumor drugs called BET inhibitors and ...
14 hours ago
0
4
Could creatine help depression? What five clinical trials show so far
Could the same supplement many people take to build muscle also help treat depression?
15 hours ago
0
3
Psychedelics not yet ready for clinical use in ADHD treatment, study finds
In recent years, there has been growing interest among adults with ADHD in the practice of microdosing classic psychedelics such as psilocybin and LSD. The internet is full of personal accounts describing improved concentration, ...
16 hours ago
0
2
GLP-1 drugs outperform SGLT-2 drugs for patients with Afib and type 2 diabetes
Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney disease and heart failure. These risks are significantly exacerbated if a type 2 diabetes diagnosis is ...
17 hours ago
0
3
UK-US trade deal will mean the NHS has to divert billions from other services to pay more for new medicines
Around £45 billion in NHS funding will be diverted from other NHS care by 2036 to pay more for new medicines under the UK-U.S. trade deal agreed last December unless more funding is made available to cover the additional ...
14 hours ago
0
4
The hidden risks of gray‑market peptides: Why women face greater danger
A wave of unregulated peptides is sweeping the wellness world, sold online with bold promises about muscle gain, anti-aging and fat loss. But concern is growing about side effects, and almost nobody is asking whether these ...
17 hours ago
0
3
Whether children receive opioids after surgery varies by hospital and procedure type
Whether children receive an opioid prescription after surgery varies substantially by procedure type and hospital, according to a new national analysis published in the Journal of the American College of Surgeons. The study ...
17 hours ago
0
0
FDA scientists warn against expanded peptide access as Kennedy reshapes advisory panel
Federal health scientists are urging caution about expanding access to controversial peptide drugs, even as the U.S. Food and Drug Administration (FDA) reshapes the advisory panel that will consider whether to loosen those ...
14 hours ago
0
1
Bacteria's 'mix-and-match' code could create new cancer-fighting drugs
A team of researchers at the University of Warwick and Monash University has solved a puzzle that has stumped drug developers for decades: how bacteria naturally create multiple versions of powerful cancer therapies. The ...
Jul 1, 2026
0
5
Acute respiratory distress syndrome patients improve with experimental monoclonal antibody treatment
Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress syndrome, or ARDS. A frequent cause of death during the COVID-19 pandemic, ARDS occurs when an inflammatory ...
Jul 1, 2026
0
2
Substantial rise in antinausea medicine use during pregnancy, New Zealand study shows
There has been a fivefold increase in the use of antinausea medicines during Aotearoa New Zealand pregnancies, a University of Otago—Ōtākou Whakaihu Waka-led study has found.
Jul 1, 2026
0
2
GLP-1 medications linked to fewer deaths and amputations in people with type 2 diabetes and PAD
According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist (GLP-1 RA) medications reduce the number of deaths, amputations and hospitalizations among people with ...
Jul 1, 2026
0
4
Billions of doses later: Global review confirms mRNA vaccines are safe, effective and full of promise
A sweeping global review led by researchers at the University of British Columbia has found that mRNA vaccines—now administered billions of times worldwide—are safe and highly effective at preventing infectious diseases like ...
Jun 30, 2026
0
20
Repurposed epilepsy drug could be used to boost vaccine protection among elderly
A drug commonly used to treat epilepsy could be repurposed to significantly boost the response to vaccines in humans, helping protect those for whom the vaccine is less effective, such as older adults or immunocompromised ...
Jun 30, 2026
0
6
New postnatal gene therapy offers hope for congenital hearing loss
Hereditary hearing loss affects millions globally, with mutations in the SLC26A4 gene among the most common genetic triggers, particularly across Asian populations. This condition leads to severe-to-profound deafness accompanied ...
Jun 30, 2026
0
4
Treating Duchenne muscular dystrophy before symptoms emerge may improve motor function, clinical trial suggests
At Binghamton University, researchers were among the first to find ways to help patients with Duchenne muscular dystrophy (DMD) through the development of an effective drug. Now, they are continuing that work, looking to ...
Jun 30, 2026
0
4
Australia relaxes psychedelic therapy oversight despite limited safety evidence
Psilocybin (the active ingredient of magic mushrooms) and MDMA (the active ingredient in ecstasy) are psychedelic or hallucinogenic drugs that can change how a person sees things and feels.
Jun 30, 2026
0
4
Mussel-inspired vaccine aims to close the immunization gap with long-lasting immune protection
A research team in Korea has developed a vaccine technology that delivers long-lasting immune protection from a single dose by applying the powerful underwater adhesion mechanism of mussels. The work is drawing attention ...
Jun 30, 2026
0
3
Melatonin may ease chronic pain, study finds
A sleep supplement widely used to treat insomnia could help reduce reliance on some of the most common and potentially harmful pain medications, new research from the University of Sydney suggests.
Jun 30, 2026
0
9
African genetic data could change how essential medicines are prescribed
The dosage information for drugs used in HIV treatment, malaria, cancer care, pain management and transplantation is largely based on data from European patients and fails to include vital information about how essential ...
Jun 30, 2026
0
3
Popular GLP-1 weight loss drugs are being misused by people struggling with eating disorders, research reveals
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Ozempic or Wegovy, have revolutionized type 2 diabetes and weight-loss management, but they have also led to some unfortunate outcomes. A recent study in JAMA ...
Cancer cell 'degraders' target two proteins at once to defeat treatment resistance
Researchers from two Technion faculties have jointly developed a new compound and demonstrated its effectiveness against aggressive tumor cells.
Jun 29, 2026
0
9
Three-in-one vaccine shows promise against 'tripledemic'
Flu season is no longer just flu season. Since 2022, the health care community has faced what's known as a "tripledemic" of seasonal influenza, COVID-19 and respiratory syncytial virus (RSV). That may mean the flu shot needs ...
Jun 29, 2026
0
14
